BioPharma Credit (LON:BPCR) Trading Up 0.1% – Still a Buy?
by Jessica Moore · The Cerbat GemBioPharma Credit (LON:BPCR – Get Free Report)’s stock price shot up 0.1% on Wednesday . The stock traded as high as GBX 0.87 ($0.01) and last traded at GBX 0.86 ($0.01). 886,416 shares traded hands during mid-day trading, a decline of 37% from the average session volume of 1,397,234 shares. The stock had previously closed at GBX 0.86 ($0.01).
BioPharma Credit Stock Performance
The firm’s 50 day moving average price is GBX 0.87 and its two-hundred day moving average price is GBX 0.88. The firm has a market cap of £10.30 million, a PE ratio of 10.73 and a beta of 0.22.
About BioPharma Credit
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than BioPharma Credit
- How to Choose Top Rated Stocks
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is a Special Dividend?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year